Commercial histories show transition work well before the recent affiliation increase: PARAGON says its core consultant group worked together from 1988, although PARAGON itself was founded in 2001; an ADS member describes the alliance as formed in 1995. These are commercial self-descriptions, not a national brokerage census.
System lesson · Broker history
Brokers existed before DSOs. Institutional capital changed the work and the stakes.
Dental transition advisers operated decades before the recent rise in DSO and private-equity affiliation. More institutional buyers can change marketing, valuation language, financing, and deal terms. Affiliation trends alone do not establish that brokers caused ownership to decline.
Founder history · firsthand
Four of six near-retirement dentists I worked with had received their practices from unrelated predecessors because the predecessor cared who would continue treating the patients and families.
Stewardship and monetization are not the same sale instruction.
This account establishes what the founder was told, not how common gifts were. It gives DenQAI a useful contrast: a practice can be valued as cash flow and still be treated as a clinical trust.
A cautious timeline
What the available evidence can support.
ADA workforce data place DSO affiliation at 7.2% in 2015. A separate peer-reviewed study reports private-equity (PE) affiliation at 6.6% in 2015 and 12.8% in 2021. The measures have different definitions and should not be added together or treated as the same ownership statistic.
The ADA’s summary of peer-reviewed research reports fewer than 20 documented PE dental transactions annually through 2015, followed by 62 in 2019, 46 in 2020, and 96 in 2021. The series is not a complete national transaction census.
ADA reports DSO affiliation at 16.1% in 2024. Some transition firms openly market DSO, private-equity, or M&A services, documenting adaptation to institutional buyers—not improper conduct in any particular sale.
Pre-sale performance
Separate durable improvements from a temporary peak.
Adding an associate, reducing claim errors, or improving recall may strengthen a practice. Higher collections alone cannot establish that the improvement will survive the seller’s departure or fit the buyer’s services, staffing, and clinical approach.
Which part of this performance can I sustain after the transition?
Compare several years and recent monthly records. Request provider-level production, actual hours, patient cohorts, procedure mix, deferred expenses, staff commitments, payer portability, and the recurring cash needed to deliver the buyer’s model. A change in procedure volume is a question for independent clinical review; it does not establish unnecessary treatment.
Supported and unsupported
Teach incentives without inventing intent.
- A seller-paid broker is not automatically the buyer’s adviser.
- Institutional buyers can qualify, price, and close differently from individuals.
- Some firms openly offer DSO, PE, or M&A sale services.
- A seller can put successor type and stewardship instructions in writing.
- That brokers caused declining ownership.
- That hidden prices exist only to inflate valuation.
- That every broker steers sellers to DSOs.
- That a service relationship proves referral fees, shared ownership, or data sharing.
Primary evidence
Read the claims at their actual ceiling.
PARAGON commercial historyConsultant group since 1988; firm founded in 2001ADS member commercial historyMember account of the alliance’s 1995 formationADA U.S. Dentist Workforce 2025DSO affiliation, career stage, ownership contextHealth Affairs researchPE affiliation, 2015–2021; public abstract, not a quality or causality findingADA research summaryDocumented transaction series and limits
Seller work product
If buyer type matters, make it part of the assignment.
Do not rely on an unwritten hope that the practice will reach patient-centered private buyers.
Download seller marketing instructions